J&J COVID-19 Vaccine Advisory

A ‘rare and severe’ type of blood clot has recently been seen in six people after the administration of Johnson & Johnson’s COVID-19 vaccine. The FDA and CDC have recommended pausing further administration of the vaccine pending further review. Due to this uncertainty, the IMSMP recommends that our patients avoid the J & J vaccine for now until further information becomes available.


News Date : 
Tuesday, April 13, 2021 (All day)


Because you deserve only the best in MS healthcare. Experience the difference.

Newsletter Sign Up

Join our mailing list today!  Receive the latest information and updates happening in MS research, treatment and care including, Healing MS, the IMSMP newsletter.

* We don’t share your information with anyone.